FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying the effects of oxaliplatin, leucovorin and fluorouracil-when
given together with Cetuximab and radiation therapy and radiation therapy to see how they
work in treating patients with stage III esophageal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)